Geisinger awarded Keystone Innovation Starter Kit Grant

MaY 15, 2006 DANVILLE — Geisinger Clinic has received a $202,000 grant from the state to help fund genomics research and nurture a bioscience industry in the central Susquehanna Valley.

Geisinger will use the money to support research into how individual patients, based on their genetic make-up, will respond to various drug treatments and medical devices. The clinic is currently searching for a senior researcher with experience in bioinformatics and genetic epidemiology. The starter kit grant will boost recruiting efforts by funding program supports like a research fellow, six college student interns, office computers and equipment, plus laboratory needs. Geisinger provides the researcher salary, benefits, tuition support and investment in the genomics project infrastructure.

Bioinformatics refers to using computers to store and analyze biological data; in this case, health records. Genetic epidemiology is how diseases impact people based on traits inherited from their parents.

“This research will help personalize medical treatment because doctors will be able to predict how someone will respond to a drug or device before treatment begins,” said Dr. Glenn Steele, M.D., Ph.D., President and CEO of Geisinger Health System. “We’re excited to be a leader in developing this industry that can improve patient care while providing great economic opportunities for our region.”

Geisinger Health System, through Geisinger Ventures, is part of the Greater Susquehanna Keystone Innovation Zone with partners Bloomsburg University, Bucknell University, Susquehanna University, Columbia Alliance for Economic Growth and Ben Franklin Technology Partners Northeast PA.